Stroke and silent cerebrovascular disease.
Stroke is personal to me as my mom had several small strokes, a near fatal stroke and finally one that did end her life. We were able to restore her brain function after the near fatal stroke with occupational therapy and natural medicines. Unfortunately, I could not offer her I.V. ozone because of geographical distance. Her doctors had the job of balancing her predisposition of having a stroke with managing her Afib. This created a biochemical conflict. I.V. Ozone would have been a good choice for both.
Primary stroke prevention is indicated in patients with silent brain infarcts, white matter hyperintensities, or microbleeds. Three cardinal manifestations of silent cerebrovascular disease include silent brain infarcts, MRI white matter hyperintensities of presumed vascular origin, and cerebral microbleeds. Decades of epidemiologic research shows that silent cerebrovascular disease is common and associated with an increase risk of stroke and dementia. There is strong and consistent evidence that silent cerebrovascular disease is a common problem of aging and that silent brain infarcts and white matter hyperintensities are strongly associated with future symptomatic stroke risk, entailing a two- to threefold increase in relative risk, even after controlling for vascular risk factors such as hypertension. In patients with cerebral microbleeds, evidence suggests that those treated with thrombolysis for acute ischemic stroke have a moderately increased risk of symptomatic intracranial hemorrhage, but little prospective evidence indicates the risk of symptomatic hemorrhage in patients who receive anticoagulation.
Besides reducing stress, patients can take Xymogen's Nattokinase, MaxDeFlam and Omega MonoPure 1300 EC as valuable natural anti-coagulants.
Dr. E. and I have given 10 pass MAH ozone treatments to patients who have had strokes within two weeks of emergent care. There are specific German remedies to use to help repair and restore brain function. Patients responded well to the treatment as is cited in the international literature. If you have had a stroke with oxygen deficits - consider I.V. Ozone therapy. All therapies are MD ordered in NYS.
1. Primary stroke prevention is indicated for __________, according to the American Heart Association (AHA) and the American Stroke Association (ASA).
2. True or False. MRI white matter hyperintensities may indicate silent cerebrovascular disease.
4. Silent brain infarcts and white matter hyperintensities within silent cerebrovascular disease are associated with an approximately __________-fold increased risk for symptomatic stroke.
5. Patients with cerebral microbleeds who are treated with thrombolysis for acute ischemic stroke have a __________ risk of symptomatic intracranial hemorrhage.
1. D. A, B or C
2. A. True
3. C. A and B
4. A. Two to Three
5. C. Moderately Increased
For complete information, see:
“Stroke Prevention in Patients With Silent Cerebrovascular Disease.”